Literature DB >> 15871519

Intraventricular chordoid meningioma presenting with Castleman disease due to overproduction of interleukin-6. Case report.

Toru Arima1, Atsushi Natsume, Hisashi Hatano, Norimoto Nakahara, Mitsugu Fujita, Dai Ishii, Toshihiko Wakabayashi, Manabu Doyu, Tetsuro Nagasaka, Jun Yoshida.   

Abstract

A rare case of chordoid meningioma in the lateral ventricle observed in an adult is reported. The first clinical manifestation of the disease was a prolonged fever of unknown origin. Abnormalities in the patient's blood chemistry, principally polyclonal hypergammaglobulinemia (immunoglobulin [Ig]G, IgA, and markedly IgE) and an elevated serum level of C-reactive protein, were associated with the disease. The tumor was histologically confirmed to be a chordoid meningioma, and its surgical removal resulted in complete resolution of the patient's symptoms. By combining reverse transcription-polymerase chain reaction and immunohistochemical analysis, it may be shown that cytokine production, including that of interleukin (IL)-6, IL-1beta, and vascular endothelial growth factor, plays a role in the pathogenesis of chordoid meningioma associated with Castleman syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15871519     DOI: 10.3171/jns.2005.102.4.0733

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  10 in total

1.  Chordoid meningioma: a clinicopathologic study of 11 cases at a single institution.

Authors:  Jui-Wei Lin; Jih-Tsun Ho; Yu-Jun Lin; You-Ting Wu
Journal:  J Neurooncol       Date:  2010-05-09       Impact factor: 4.130

2.  Chordoid meningioma, an uncommon variant of meningioma: a clinicopathologic study of 12 cases.

Authors:  S Epari; M C Sharma; C Sarkar; A Garg; A Gupta; V S Mehta
Journal:  J Neurooncol       Date:  2006-04-21       Impact factor: 4.130

3.  Report of two cases of chordoid meningioma in patients with Castleman syndrome.

Authors:  Gentian Kaloshi; Manila Antonelli; Gjergj Vreto; Artid Lame; Ilda Kerri; Teona Bushati; Arben Rroji; Mentor Petrela
Journal:  J Neurooncol       Date:  2010-12-07       Impact factor: 4.130

Review 4.  Predictors of recurrence in the management of chordoid meningioma.

Authors:  Winward Choy; Leonel Ampie; Jonathan B Lamano; Kartik Kesavabhotla; Qinwen Mao; Andrew T Parsa; Orin Bloch
Journal:  J Neurooncol       Date:  2015-09-26       Impact factor: 4.130

5.  Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.

Authors:  Ankur R Sangoi; Mohanpal S Dulai; Andrew H Beck; Daniel J Brat; Hannes Vogel
Journal:  Am J Surg Pathol       Date:  2009-05       Impact factor: 6.394

Review 6.  Natural history of intraventricular meningiomas: systematic review.

Authors:  Benedito Jamilson Araújo Pereira; Antônio Nogueira de Almeida; Wellingson Silva Paiva; Paulo Henrique Pires de Aguiar; Manoel Jacobsen Teixeira; Suely Kazue Nagahashi Marie
Journal:  Neurosurg Rev       Date:  2018-08-15       Impact factor: 3.042

7.  Chordoid meningioma: a report of ten cases.

Authors:  Martha Lilia Tena-Suck; Miguel Angel Collado-Ortìz; Citlaltepetl Salinas-Lara; Rabindhranath García-López; Noemi Gelista; Daniel Rembao-Bojorquez
Journal:  J Neurooncol       Date:  2010-01-22       Impact factor: 4.130

8.  Cerebral angiitis associated with subarachnoid hemorrhage in Castleman's disease: report of two cases.

Authors:  Jun Tanaka; Atsushi Fujita; Kohkichi Hosoda; Eiji Kohmura
Journal:  BMC Neurol       Date:  2016-05-04       Impact factor: 2.474

9.  Acute Hydrocephalus Caused by Cerebellar Abscess in HIV-Negative Castleman's Disease.

Authors:  Angelo Rusconi; Alessandro Dario; Gianluca Agresta; Sergio Balbi
Journal:  Asian J Neurosurg       Date:  2019 Jul-Sep

10.  High-grade spheno-orbital meningioma in patients with systemic lupus erythematosus: Two case reports and literature review.

Authors:  Sarah Bin Abdulqader; Nasser Almujaiwel; Wafa Alshakweer; Gmaan Alzhrani
Journal:  Surg Neurol Int       Date:  2020-10-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.